Morgan Keegan Starts Coverage on 10 Healthcare Stocks: ABT, BSX, STJ at Outperform, JNJ, MDT at Market Perform
Get Alerts ABT Hot Sheet
Price: $113.48 --0%
Rating Summary:
18 Buy, 10 Hold, 1 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 13 | Down: 10 | New: 10
Rating Summary:
18 Buy, 10 Hold, 1 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 13 | Down: 10 | New: 10
Join SI Premium – FREE
In the Healthcare group Friday morning, Morgan Keegan's Jan Wald initiated coverage on the following stocks:
- Abbott Labs (NYSE: ABT) with an Outperform rating and a $61 price target
- Boston Scientific (NYSE: BSX) with an Outperform rating and a $8 price target
- St. Jude (NYSE: STJ) with an Outperform rating and a $60 price target
- DexCom (Nasdaq: DXCM) with an Outperform rating and a $18 price target
- HeartWare (Nasdaq: HTWR) with an Outperform rating and a $87 price target
- J&J (NYSE: JNJ) with a Market Perform rating and a $70 price target
- Medtronic (NYSE: MDT) with a Market Perform rating and a $43 price target
- Edwards Lifesciences (NYSE: EW) with a Market Perform rating and a $97 price target
- Thoratec (Nasdaq: THOR) with a Market Perform rating and a $35 price target
- AtriCure (Nasdaq: ATRC) with a Market Perform rating and a $14 price target
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays Reinstates LondonMetric Property PLC (LMP:LN) (LNSPF) at Overweight
- Piper Sandler Starts TransMedics Group (TMDX) at Overweight, believes strong growth will continue for several more years
- RBC Capital Starts Jasper Therapeutics (JSPR) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Morgan Keegan & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!